Genetic association analysis of CNR1 and CNR2 polymorphisms with schizophrenia in a Korean population
暂无分享,去创建一个
H. Shin | Jaeuk Hwang | Chul-Soo Park | B. Kim | Cheol-Soon Lee | J. Bae | Migyung Lee | B. Park | S. Woo | Jason-Y. Kim | Jeong Hyun Kim | W. Choi | Bomi Kim | T-M Shin | Jason Y.ongha Kim | Chul S.oo Park | Woo H.yuk Choi | J. Kim
[1] Y. Goshima,et al. Identification of axon‐enriched MicroRNAs localized to growth cones of cortical neurons , 2014, Developmental neurobiology.
[2] Xiao-li Cheng,et al. Association of Single-Nucleotide Polymorphisms in the Cannabinoid Receptor 2 Gene with Schizophrenia in the Han Chinese Population , 2013, Journal of Molecular Neuroscience.
[3] Li-Huei Tsai,et al. MicroRNAs in learning, memory, and neurological diseases. , 2012, Learning & memory.
[4] G. Westbrook,et al. Dentate gyrus neurogenesis, integration and microRNAs , 2012, Behavioural Brain Research.
[5] J. W. Kim,et al. Neuregulin 3 does not confer risk for schizophrenia and smooth pursuit eye movement abnormality in a Korean population , 2011, Genes, brain, and behavior.
[6] J. Mattick,et al. MicroRNA regulation of neural plasticity and memory , 2011, Neurobiology of Learning and Memory.
[7] M. Itokawa,et al. Brain Cannabinoid CB2 Receptor in Schizophrenia , 2010, Biological Psychiatry.
[8] M. Hutz,et al. Cannabinoid Type-1 Receptor Gene Polymorphisms Are Associated with Central Obesity in a Southern Brazilian Population , 2008, Disease markers.
[9] Vernell S. Williamson,et al. Cannabinoid receptor 1 gene association with nicotine dependence. , 2008, Archives of general psychiatry.
[10] P. Gorwood,et al. The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia , 2008, European Neuropsychopharmacology.
[11] H. Emrich,et al. No association of CNR1 gene variations with susceptibility to schizophrenia , 2007, Neuroscience Letters.
[12] J. Gelernter,et al. CNR1 Variation Modulates Risk for Drug and Alcohol Dependence , 2007, Biological Psychiatry.
[13] J. Hoenicka,et al. (AAT)n repeat in the cannabinoid receptor gene, CNR1: association with schizophrenia in a Spanish population , 2006, European Archives of Psychiatry and Clinical Neuroscience.
[14] M. Krebs,et al. (AAT)n repeat in the cannabinoid receptor gene (CNR1): association with cocaine addiction in an African-Caribbean population , 2006, The Pharmacogenomics Journal.
[15] R. Hampson,et al. Cannabinoid physiology and pharmacology: 30 years of progress , 2004, Neuropharmacology.
[16] M. Fritzsche. Are cannabinoid receptor knockout mice animal models for schizophrenia? , 2001, Medical hypotheses.
[17] S. Tsai,et al. Association study of a cannabinoid receptor gene (CNR1) polymorphism and schizophrenia. , 2000, Psychiatric genetics.
[18] D. Collier,et al. No association between (AAT)n repeats in the cannabinoid receptor gene (CNR1) and heroin abuse in a Chinese population , 2000, Molecular Psychiatry.
[19] E. Gershon,et al. Suggestive evidence for a schizophrenia susceptibility locus on chromosome 6q and a confirmation in an independent series of pedigrees. , 1997, Genomics.
[20] D. Piomelli,et al. Role of the endogenous cannabinoid system as a modulator of dopamine transmission: Implications for Parkinson’s disease and schizophrenia , 2009, Neurotoxicity Research.
[21] F. Bermúdez-Silva,et al. The endocannabinoid system: physiology and pharmacology. , 2005, Alcohol and alcoholism.
[22] H Ujike,et al. CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia , 2002, Molecular Psychiatry.
[23] R. Murray,et al. Genetic association between alleles of pancreatic phospholipase A2 gene and bipolar affective disorder , 1995, Psychiatric genetics.